You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Familial multiple primary cancer risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Familial Prostate Cancer Trial (Panel sequencing, whole exome sequencing, whole genome sequencing)

Not yet recruiting
  • Prostate Cancer
  • Familial Prostate Cancer
  • Panel sequencing, whole exome sequencing, whole genome sequencing
  • (no location specified)
Dec 26, 2022

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

l, Laboratory and Epidemiologic Characterization of Individuals

Completed
  • Familial Ovarian Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Candidates for Hereditary Pancreatic Cancer Testing Trial in Verona (Saliva swab testing)

      Recruiting
      • Candidates for Hereditary Pancreatic Cancer Testing
      • Saliva swab testing
      • Verona, Italy
        Chirurgia generale e del Pancreas Azienda Ospedaliera Universita
      Feb 13, 2023

      Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Wuhan, Hubei, China
        Institute of Hematology, Union Hospital, Tongji Medical College,
      Nov 18, 2023

      Registry of Subjects at Risk of Pancreatic Cancer

      Recruiting
      • Familial Pancreatic Cancer
      • +6 more
      • MRCP
      • Endoultrasonography
      • Rozzano, Milan, Italy
      • +3 more
      Jan 12, 2023

      Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,

      Not yet recruiting
      • Colorectal Adenomatous Polyp
      • +3 more
      • Biopsy
      • +5 more
      • Ann Arbor, Michigan
      • +4 more
      Jan 3, 2023

      Biomarker for Infection Risk in CLL and MM

      Not yet recruiting
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Screening
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      May 3, 2023

      High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,

      Recruiting
      • High-risk Smoldering Multiple Myeloma
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Aug 11, 2022

      TCM Constitution, Pattern Types, and Disease Factors in Primary

      Not yet recruiting
      • Medicine, Chinese Traditional
      • +3 more
      • Constitution in Chinese Medicine Questionnaire
      • (no location specified)
      Nov 24, 2023

      Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

      Not yet recruiting
      • Multiple Myeloma
      • +2 more
      • Discontinuation of maintenance treatment
      • Cork, Ireland
        Cork University Hospital
      May 10, 2023

      Cervical Cancer, Prevention Trial in Ramotswa (Automated visual evaluation)

      Active, not recruiting
      • Cervical Cancer
      • Prevention
      • Automated visual evaluation
      • Ramotswa, Botswana
        Bamalete Lutheran Hospital
      Feb 1, 2023

      Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 8, 2023

      Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

      Not yet recruiting
      • Multiple Cancer
      • Colorectal Cancer
      • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
      • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
      • (no location specified)
      Aug 20, 2023

      Intervention for Vulnerable Informal Caregivers at Increased

      Recruiting
      • Informal Caregivers
      • +3 more
      • Personalised primary prevention intervention
      • Lyon, France
        Centre Leon Berard
      Jul 22, 2022

      Resilience in Pulmonary Arterial Hypertension and Genetically

      Recruiting
      • Idiopathic Pulmonary Arterial Hypertension
      • +3 more
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Dec 9, 2022

        Multiple Primary Lung Cancer Trial in Shanghai (ENB guided MWA combined with VATS, sequential surgery)

        Recruiting
        • Multiple Primary Lung Cancer
        • ENB guided MWA combined with VATS
        • sequential surgery
        • Shanghai, Shanghai, China
          Ruijin Hospital Affiliated to Shanghai Jiao Tong University Scho
        Jan 6, 2023

        Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)

        Active, not recruiting
        • Multiple Myeloma
        • High Risk Smoldering Multiple Myeloma
        • Basking Ridge, New Jersey
        • +5 more
        Nov 15, 2022

        Breast Tumor Trial in New York (RealRisks, BNAV)

        Active, not recruiting
        • Breast Neoplasm
        • RealRisks
        • BNAV
        • New York, New York
          Columbia University Medical Center
        Aug 16, 2022

        Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)

        Recruiting
        • Nasopharyngeal Carcinoma
        • Intensity-Modulated Radiotherapy
        • Reduction CTVp1
        • Non-reduction CTVp1
        • Zhongshan, Guangdong, China
          Zhongshan City People's Hospital
        Aug 8, 2023

        Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

        Active, not recruiting
        • Multiple Myeloma
        • High-Risk Cancer
        • Bortezomib following nonmyeloablative allogeneic transplant
        • Montreal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Aug 22, 2022

        Obesity, Smoking Cessation, Physical Inactivity Trial in Chicago (multiple behavior change therapy)

        Not yet recruiting
        • Obesity
        • +2 more
        • multiple behavior change therapy
        • Chicago, Illinois
          Northwestern University-Feinberg School of Medicine
        Jan 6, 2023

        Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

        Recruiting
        • Adenine Phosphoribosyltransferase Deficiency
        • +83 more
          • Bristol, South West, United Kingdom
            Zoe Plummer
          Sep 26, 2023

          Colorectal Cancer Prevention Trial in Lyon (Low risk, Moderate risk, High risk)

          Not yet recruiting
          • Colorectal Cancer Prevention
          • Low risk
          • +2 more
          • Lyon, France
            Centre Léon Bérard (CLB)
          Oct 5, 2022